HCPCS Q2039: Influenza Virus Vaccine, Not Otherwise Specified
HCPCS Level II code Q2039 represents an influenza virus vaccine, not otherwise specified, used for administration of seasonal influenza immunization; the service is a vaccine product for prevention of influenza and is typically provided in outpatient and clinic settings, including physician offices, pharmacies, and community health clinics.
For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.
Customize your policy alerts
Sign up for hcpcs Q2039 policy alerts
Get alerted when payer policies referencing Q2039 are released or updated.
Monitor payer policy activity